Humana (HUM) Q4 2025 (USD): adj. EPS -3.96 (exp. -4.00), Revenue 32.5bln (exp. 32.04bln)

Humana's Q4 earnings report shows an adjusted EPS that slightly beat expectations, alongside stronger revenue than anticipated.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

QXO (QXO) to purchase Kodiak Building Partners for c. USD 2.2bln; The transaction is expected to be highly accretive to 2026 earnings and will expand QXO’s current addressable market to more than USD 200bln

Niowave and Novartis (NOVN SW) enter global actinium-225 supply agreement to advance next-generation cancer therapies

Humana (HUM) Q4 2025 (USD): adj. EPS -3.96 (exp. -4.00), Revenue 32.5bln (exp. 32.04bln)

EU Commission is reportedly consulting on an update to shareholder rights rules

Vertiv (VRT) Q4 2025 (USD): adj. EPS 1.36 (exp. 1.29), Revenue 2.88bln (exp. 2.88bln)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Q4 adj. benefit ratio 93% (vs 91.3% Y/Y)

COMMENTARY:

  • Remains confident in strategy and 2026 membership outlook 

GUIDANCE:

  • FY EPS view 8.89 (exp. 11.91)
Context

However, the FY EPS guidance is significantly below consensus, which could raise concerns about future profitability despite the company's confidence in its strategy and 2026 membership outlook. Traders should monitor how the market reacts to these mixed signals, particularly in light of the forward outlook.

Related headlines

The whole workspace, free to try.

Try it free